TY - JOUR
T1 - A case of pancreatic ductal adenocarcinoma growing within the pancreatic duct mimicking an intraductal tubulopapillary neoplasm
AU - Sato, Ryosuke
AU - Matsumoto, Kazuyuki
AU - Uka, Mayu
AU - Takagi, Kosei
AU - Nishida, Kenji
AU - Tanaka, Takehiro
AU - Fujii, Yuki
AU - Tsutsumi, Koichiro
AU - Horiguchi, Shigeru
AU - Otsuka, Motoyuki
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/4
Y1 - 2025/4
N2 - We herein report a case of pancreatic ductal adenocarcinoma (PDAC) that developed within the pancreatic duct and was initially diagnosed as an intraductal tubulopapillary neoplasm (ITPN). A 76-year-old man presented with weight loss and main pancreatic duct dilation. The imaging studies revealed a 30-mm hypovascular tumor within the main duct of the pancreatic head. An endoscopic examination with a biopsy revealed high-grade atypical epithelial cells with immunostaining patterns suggestive of ITPN. Following robot-assisted pancreaticoduodenectomy, postoperative pathology revealed conflicting features: nodular/cribriform infiltrations typical of ITPN and non-lobular replacement with scattered infiltrations characteristic of PDAC. A comprehensive genomic profiling test detected KRAS and TP53 mutations, leading to the final diagnosis of PDAC (fT3N1aM0, stage IIB). The patient received adjuvant S-1 chemotherapy and remained recurrence-free for 15 months post-surgery. This case highlights the diagnostic challenges of differentiating intraductal pancreatic tumors and demonstrates the utility of integrating genetic testing with conventional diagnostic modalities for an accurate diagnosis and appropriate treatment selection.
AB - We herein report a case of pancreatic ductal adenocarcinoma (PDAC) that developed within the pancreatic duct and was initially diagnosed as an intraductal tubulopapillary neoplasm (ITPN). A 76-year-old man presented with weight loss and main pancreatic duct dilation. The imaging studies revealed a 30-mm hypovascular tumor within the main duct of the pancreatic head. An endoscopic examination with a biopsy revealed high-grade atypical epithelial cells with immunostaining patterns suggestive of ITPN. Following robot-assisted pancreaticoduodenectomy, postoperative pathology revealed conflicting features: nodular/cribriform infiltrations typical of ITPN and non-lobular replacement with scattered infiltrations characteristic of PDAC. A comprehensive genomic profiling test detected KRAS and TP53 mutations, leading to the final diagnosis of PDAC (fT3N1aM0, stage IIB). The patient received adjuvant S-1 chemotherapy and remained recurrence-free for 15 months post-surgery. This case highlights the diagnostic challenges of differentiating intraductal pancreatic tumors and demonstrates the utility of integrating genetic testing with conventional diagnostic modalities for an accurate diagnosis and appropriate treatment selection.
KW - Genetic testing
KW - Intraductal tubulopapillary neoplasm
KW - Pancreatic carcinoma
KW - Pancreatic intraductal neoplasms
UR - http://www.scopus.com/inward/record.url?scp=85217658121&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85217658121&partnerID=8YFLogxK
U2 - 10.1007/s12328-025-02098-y
DO - 10.1007/s12328-025-02098-y
M3 - Article
C2 - 39910028
AN - SCOPUS:85217658121
SN - 1865-7257
VL - 18
SP - 376
EP - 382
JO - Clinical Journal of Gastroenterology
JF - Clinical Journal of Gastroenterology
IS - 2
ER -